A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder
Phase 1
Completed
- Conditions
- SchizophreniaBipolar Disorder
- First Posted Date
- 2009-05-04
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 64
- Registration Number
- NCT00892125
A Study of the Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese Volunteers
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2009-05-04
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 20
- Registration Number
- NCT00892320
A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Phase 1
Completed
- Conditions
- Attention Deficit Hyperactivity DisorderAttention Deficit Disorders With Hyperactivity
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2010-04-16
- Target Recruit Count
- 18
- Registration Number
- NCT00890240
A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Phase 1
Completed
- Conditions
- Attention Deficit Hyperactivity DisorderAttention Deficit Disorders With Hyperactivity
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2010-04-16
- Target Recruit Count
- 18
- Registration Number
- NCT00890292
A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
Phase 2
Completed
- Conditions
- Attention Deficit Hyperactivity Disorder
- Interventions
- Drug: JNJ-31001074 3 mg/dDrug: JNJ-31001074 1 mg/dDrug: JNJ-31001074 10 mg/dDrug: Placebo
- First Posted Date
- 2009-04-13
- Last Posted Date
- 2013-03-04
- Target Recruit Count
- 430
- Registration Number
- NCT00880217
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2009-03-30
- Last Posted Date
- 2014-05-22
- Target Recruit Count
- 25
- Registration Number
- NCT00871507
A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2009-02-13
- Last Posted Date
- 2011-06-09
- Target Recruit Count
- 188
- Registration Number
- NCT00843687
A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone
Phase 1
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2009-02-06
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 74
- Registration Number
- NCT00838669
Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2009-01-26
- Last Posted Date
- 2011-05-18
- Target Recruit Count
- 53
- Registration Number
- NCT00828958
Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia
Phase 1
Completed
- Conditions
- Psychotic DisordersSchizophrenia
- Interventions
- First Posted Date
- 2009-01-13
- Last Posted Date
- 2014-05-21
- Target Recruit Count
- 24
- Registration Number
- NCT00821600
© Copyright 2025. All Rights Reserved by MedPath